These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20073998)

  • 1. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases.
    Chakraborty S; Shukla D; Mishra B; Singh S
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):237-50. PubMed ID: 20073998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carvedilol controlled-release in cardiovascular disease.
    Fonarow GC
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
    [No Abstract]   [Full Text] [Related]  

  • 4. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betablockers: old concept in a modern approach.
    Hansson BG
    Scand Cardiovasc J Suppl; 1998; 47():57-9. PubMed ID: 9540134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol: something else than a simple betablocker?
    Palazzuoli A; Calabria P; Verzuri MS; Auteri A
    Eur Rev Med Pharmacol Sci; 2002; 6(6):115-26. PubMed ID: 12776805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL
    Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers in heart failure: potential of carvedilol.
    Fowler MB
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S62-7. PubMed ID: 8098065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilating versus first-generation β-blockers for cardiovascular protection.
    Fares H; Lavie CJ; Ventura HO
    Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ; Hackam DG
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
    J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical considerations for switching beta-blockers in heart failure patients.
    Abraham WT; Iyengar S
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S36-44. PubMed ID: 15184837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.